Vaccine protocols /

Saved in:
Bibliographic Details
Edition:2nd ed.
Imprint:Totowa, N.J. : Humana Press, c2003.
Description:xi, 414 p. : ill. ; 24 cm.
Language:English
Series:Methods in molecular medicine ; 87
Subject:
Format: E-Resource Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4959743
Hidden Bibliographic Details
Other authors / contributors:Robinson, Andrew, 1947-
Hudson, Michael.
Cranage, Martin P.
ISBN:1588291405 (alk. paper)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000pam a22000004a 4500
001 4959743
003 ICU
005 20110428115600.0
008 030211s2003 njua b 001 0 eng
010 |a  2003044968 
020 |a 1588291405 (alk. paper) 
035 |a (OCoLC)51764263 
040 |a DNLM/DLC  |c DLC  |d NhCcYBP  |d OCoLC  |d OrLoB-B 
042 |a pcc 
050 0 0 |a QR189  |b .V2513 2003 
060 1 0 |a W1  |b ME9616JM v.87 2003 
060 1 0 |a QW 525  |b V116 2003 
082 0 0 |a 615/.372  |2 21 
245 0 0 |a Vaccine protocols /  |c edited by Andrew Robinson, Michael J. Hudson and Martin P. Cranage. 
250 |a 2nd ed. 
260 |a Totowa, N.J. :  |b Humana Press,  |c c2003. 
300 |a xi, 414 p. :  |b ill. ;  |c 24 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Methods in molecular medicine ;  |v 87 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Overview of Vaccines /  |r Gordon Ada --  |g 2.  |t Temperature-Sensitive Mutant Vaccines /  |r Craig R. Pringle --  |g 3.  |t Live Viral Vectors: Construction of a Replication-Deficient Recombinant Adenovirus /  |r Anthony R. Fooks --  |g 4.  |t Live Viral Vectors: Vaccinia Virus /  |r Caroline Staib and Gerd Sutter --  |g 5.  |t Live Viral Vectors: Semliki Forest Virus /  |r Gunilla B. Karlsson and Peter J. Liljestrom --  |g 6.  |t Development of Attenuated Salmonella Strains That Express Heterologous Antigens /  |r Frances Bowe, Derek J. Pickard, Richard J. Anderson, Patricia Londono-Arcila and Gordon Dougan --  |g 7.  |t Expression and Delivery of Heterologous Antigens Using Lactic Acid Bacteria /  |r Mark A. Reuter, Sean Hanniffy and Jerry M. Wells --  |g 8.  |t Synthetic Peptides /  |r Michael J. Francis --  |g 9.  |t Genetic Detoxification of Bacterial Toxins /  |r Mariagrazia Pizza, Maria Rita Fontana, Vincenzo Scarlato and Rino Rappuoli --  |g 10.  |t Preparation of Polysaccharide-Conjugate Vaccines /  |r Carla C. A. M. Peeters, Patrick R. Lagerman, Odo de Weers, Lukas A. Oomen, Peter Hoogerhout, Michel Beurret, Karen M. Reddin and Jan T. Poolman --  |g 11.  |t Adjuvant Formulations for Experimental Vaccines /  |r Duncan E. S. Stewart-Tull --  |g 12.  |t Incorporation of Immunomodulators into Plasmid DNA Vaccines /  |r Linda S. Klavinskis, Philip Hobson and Andrew Woods --  |g 13.  |t Microencapsulation of Vaccine Antigens /  |r David H. Jones --  |g 14.  |t Lyophilization of Vaccines: Current Trends /  |r Gerald D. J. Adams --  |g 15.  |t Stimulation of Mucosal Immunity /  |r David J. M. Lewis and Christopher M. M. Hayward --  |g 16.  |t Induction and Detection of T-Cell Responses /  |r Kingston H. G. Mills --  |g 17.  |t Construction of MHC Class I-Peptide Tetrameric Complexes for Analysis of T-Cell-Mediated Immune Responses /  |r Rachel V. Samuel and Tomas Hanke --  |g 18.  |t Assessment of Functional Antibody Responses /  |r Ray Borrow and Paul Balmer --  |g 19.  |t The Use of Complete Genome Sequences in Vaccine Design /  |r Nigel J. Saunders and Sarah Butcher --  |g 20.  |t Severe Combined Immunodeficient (SCID) Mice in Vaccine Assessment /  |r Michael J. Dennis --  |g 21.  |t Clinical Trials /  |r Paddy Farrington and Elizabeth Miller --  |g 22.  |t Assuring the Quality and Safety of Vaccines: Regulatory Expectations for Licensing and Batch Release /  |r Elwyn Griffiths and Ivana Knezevic --  |g 23.  |t DNA Vaccination: An Update /  |r Douglas B. Lowrie --  |g 24.  |t From Vaccine Research to Manufacture: A Guide for the Researcher /  |r Nigel Allison and Howard S. Tranter. 
650 0 |a Vaccines  |v Laboratory manuals. 
650 1 2 |a Vaccines. 
650 2 2 |a Drug Design. 
650 2 2 |a Genetic Techniques. 
650 2 2 |a Research Design. 
650 7 |a Vaccines.  |2 fast  |0 http://id.worldcat.org/fast/fst01163573 
655 7 |a Laboratory manuals.  |2 fast  |0 http://id.worldcat.org/fast/fst01920776 
700 1 |a Robinson, Andrew,  |d 1947-  |0 http://id.loc.gov/authorities/names/n2004021175  |1 http://viaf.org/viaf/84647906 
700 1 |a Hudson, Michael.  |0 http://id.loc.gov/authorities/names/n50028598  |1 http://viaf.org/viaf/66545758 
700 1 |a Cranage, Martin P.  |0 http://id.loc.gov/authorities/names/n2003127589  |1 http://viaf.org/viaf/44546933 
901 |a ToCBNA 
903 |a HeVa 
929 |a cat 
999 f f |i 31777d46-e5f0-5408-a582-8f94b95dbd70  |s fba21b79-f041-594d-8864-96502be67442 
928 |t Library of Congress classification  |a QR189 .V2513 2003  |l JCL  |c JCL-Sci  |i 4585045 
927 |t Library of Congress classification  |a QR189 .V2513 2003  |l JCL  |c JCL-Sci  |e VISI  |e CRERAR  |b 64263701  |i 7524040